Chuan-Shu Chen
Papers
7
Total Citations
100
H-Index
6
About
Dr. Chuan-Shu Chen is a leading urologic oncologist and researcher whose work bridges molecular genetics and robotic surgery to improve prostate cancer management. His research focuses on the role of long noncoding RNAs (lncRNAs) in prostate cancer susceptibility and progression, particularly through genetic polymorphisms. He has demonstrated that variants in GAS5 (rs145204276) significantly influence prostate cancer risk and clinicopathologic features (27 citations), while polymorphisms in MALAT1 are associated with lymph node metastasis (15 citations). Dr. Chen has also investigated how H19 polymorphisms and carbonic anhydrase 9 expression can refine risk stratification, especially for patients with low PSA levels. Beyond genetics, he is a pioneer in robotic urologic surgery, having standardized robotic-assisted laparoscopic radical prostatectomy through a landmark series of 1,200 cases performed by a single surgeon. His long-term outcomes study on robotic partial nephrectomy for renal angiomyolipoma (17 citations) further showcases his surgical expertise. With over 100 cumulative citations across his most influential works, Dr. Chen’s integrated approach—from molecular biomarkers to advanced surgical technique—is shaping personalized treatment strategies for urologic cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2Long-term outcome of robotic partial nephrectomy for renal angiomyolipoma17 citations · 2016
- 3
- 4
- 5Application in robotic urologic surgery14 citations · 2014
- 6
- 7